You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drug Sales Trends for PERIOGARD


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for PERIOGARD (2021)

Revenues by Pharmacy Type

100.0%005000100001500020000250003000035000MAIL-ORDER[disabled in preview]
Pharmacy Type Revenues
MAIL-ORDER $35,989
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

100.0%0-200020040060080010001200140016001800200022002400MAIL-ORDER[disabled in preview]
Pharmacy Type Units
MAIL-ORDER 2,354
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

100.0%005000100001500020000250003000035000OTHER FEDERAL[disabled in preview]
Payment Method Revenues
OTHER FEDERAL $35,989
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for PERIOGARD
Drug Units Sold Trends for PERIOGARD

Annual Sales Revenues and Units Sold for PERIOGARD

These sales figures are drawn from a US national survey of drug expenditures
Drug NameRevenues (USD)UnitsYear
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2021
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2020
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2019
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2018
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2017
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2016
PERIOGARD ⤷  Try for Free ⤷  Try for Free 2015
>Drug Name>Revenues (USD)>Units>Year
Showing 1 to 7 of 7 entries

Market Analysis and Sales Projections for PerioGard

Introduction to PerioGard

PerioGard, a formulation containing chlorhexidine gluconate, is a significant product in the oral hygiene and periodontal treatment markets. It is widely used for its antimicrobial properties, particularly in reducing the spread of oral bacteria and treating periodontal diseases.

Market Size and Growth

The periodontal market, which includes products like PerioGard, is experiencing substantial growth. Here are some key metrics:

  • The global periodontal market was valued at approximately $9.1 billion in 2022 and is projected to reach $24.4 billion by 2032, growing at a CAGR of 10.4% during this period[1].
  • The periodontal treatment market, specifically, was valued at $7.6 billion in 2021 and is expected to grow to $12.2 billion by 2031, with a CAGR of 4.8% from 2022 to 2031[4].

Key Drivers

Several factors are driving the demand for PerioGard and similar periodontal treatments:

  • Aging Population: The World Health Organization (WHO) notes that the risk for dental disorders increases with age, particularly for people over 50 years. The global population of people aged 60 and above is expected to nearly double from 12% to 22% between 2015 and 2050, which will significantly boost the demand for periodontal treatments[1].
  • Oral Hygiene Awareness: Growing awareness about oral hygiene and the importance of preventive dental care is another major driver. This increased awareness is leading to higher adoption rates of products like PerioGard[1].
  • Medical and Dental Tourism: The rise in medical and dental tourism is also contributing to the growth of the periodontal market, as more people seek advanced dental treatments, including those involving chlorhexidine gluconate[1].

Regional Market Analysis

The demand for PerioGard varies across different regions:

  • North America: This region dominated the global periodontal market with a market share of 34.4% in 2021. The North America chlorhexidine gluconate market, in particular, is expected to witness growth due to the increasing use of chlorhexidine gluconate in oral hygiene products[1][3].
  • Europe: Countries like the United Kingdom and Germany are significant markets. The UK held a market share of around 24.9% in the European periodontal market in 2021 and is expected to grow at a CAGR of 11.0% during the forecast period[1].
  • Asia: India and China are key markets in Asia. India accounted for about 45.2% of the South Asian periodontal market in 2021 and is projected to grow at a CAGR of 11.1% during the forecast period. China held over 43% of the East Asian periodontal market in 2021 and is expected to grow at a CAGR of 10.4%[1].

Product Demand and Supply

The demand for chlorhexidine gluconate, the active ingredient in PerioGard, is increasing due to its efficacy in reducing oral bacteria spread. However, the supply is sometimes constrained by stringent government regulations, which can impact market growth temporarily[3].

Competitive Landscape

The periodontal treatment market is competitive, with several key players:

  • Companies like Amyndas Pharmaceuticals, 3M, AMD Lasers, Inc., ASA Dental S.p.A, Biolase, Inc., and others are prominent in the market. These companies are continuously innovating and expanding their product portfolios to capture a larger market share[4].

Sales Projections

Given the growth trends and drivers, here are some sales projections for PerioGard and similar products:

  • Short-Term Projections: With the increasing awareness of oral hygiene and the growing geriatric population, sales of PerioGard are expected to rise significantly over the next few years. For instance, the North America chlorhexidine gluconate market is anticipated to witness a proliferation as the benefits of the drug become more widely recognized[3].
  • Long-Term Projections: By 2032, the global periodontal market is expected to reach $24.4 billion, indicating a substantial increase in the demand for periodontal treatments, including those involving chlorhexidine gluconate. This growth will likely translate into higher sales for products like PerioGard[1].

Challenges and Opportunities

While there are several opportunities for growth, there are also challenges to consider:

  • Regulatory Challenges: Stringent government regulations can sometimes limit the supply of chlorhexidine gluconate, affecting market growth. However, as the benefits of the drug become more evident, regulatory environments may become more favorable[3].
  • Market Penetration: Increasing market penetration, especially in regions with growing awareness of oral hygiene, presents a significant opportunity for sales growth.

Key Takeaways

  • The periodontal market, including products like PerioGard, is experiencing rapid growth driven by an aging population, increased awareness of oral hygiene, and medical and dental tourism.
  • Regional markets such as North America, Europe, and Asia are key drivers of this growth.
  • Despite regulatory challenges, the demand for chlorhexidine gluconate is expected to rise, leading to higher sales projections for PerioGard.

FAQs

  1. What is the current market size of the periodontal market?

    • The global periodontal market was valued at approximately $9.1 billion in 2022[1].
  2. What is the projected growth rate of the periodontal market?

    • The periodontal market is expected to grow at a CAGR of 10.4% from 2022 to 2032[1].
  3. Which regions are driving the growth of the periodontal market?

    • North America, Europe, and Asia, particularly countries like the USA, UK, Germany, India, and China, are driving the growth[1].
  4. What are the key drivers of the periodontal market?

    • The aging population, growing awareness of oral hygiene, and medical and dental tourism are key drivers[1].
  5. How does regulatory environment impact the market for PerioGard?

    • Stringent government regulations can sometimes limit the supply of chlorhexidine gluconate, but as the benefits become more recognized, the regulatory environment may become more favorable[3].

Cited Sources

  1. Future Market Insights: Periodontal Market Size, Industry Share, Trends – 2032.
  2. Stock Titan: Perion Reports Third Quarter 2024 Results.
  3. 6Wresearch: North America Chlorhexidine Gluconate Market (2021-2027).
  4. Transparency Market Research: Periodontal Treatment Market Size, Share, Industry Outlook - 2031.
  5. Business Wire: Perion Reports Third Quarter 2024 Results.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.